| Deler fremragende | 103,071,889 shares |
| Insideraktier | 14.096.366 shares |
| Insider ejerskab | 13,68 % |
| Total Insiders | 53 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Viridian Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Atlas Venture Fund VII L P
10% Owner -
|
6.285.160 | 419.011 | |
| Beetham Thomas W. Chief Operating Officer - [O] | 13.361 | 13.361 | |
| Bruce Booth Director - [D] | 1.351.090 | 90.073 | |
| Christopher Bowden | 24.000 | ||
|
Cohen Steven A/sac Capital Mgmt Lp
10% Owner -
|
426.162 | 426.162 | |
| Thomas Ciulla Chief Medical Officer - [O] | 762 | 762 | |
| John W Creecy Director - [D] | 5.413.126 | 360.875 | |
| Diana Escolar | 270.000 | ||
|
Fhmlsp, L.l.c.
10% Owner -
|
1.505.200 | 1.505.200 | |
|
Fhmlsp, L.p.
10% Owner -
|
1.505.200 | 1.505.200 | |
|
Fairmount Funds Management LLC
Director, 10% Owner -
[D]
|
3.914.458 | 3.914.458 | |
| Fairmount Healthcare Fund GP LLC Director - [D] | 938.233 | 1.845.813 | |
| Fairmount Healthcare Fund II GP LLC Director - [D] | 938.233 | 3.914.458 | |
| Fairmount Healthcare Fund II L.P. Director - [D] | 938.233 | 3.914.458 | |
| Fairmount Healthcare Fund L.P. Director - [D] | 938.233 | 1.845.813 | |
|
Frazier Life Sciences Public Fund, L.P.
10% Owner -
|
1.505.200 | 1.505.200 | |
| David A Gonyer Director - [D] | 1.899 | 1.899 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Seth Harmon Chief Financial Officer - [O] | 7.850 | 7.850 | |
| Peter Evan Harwin | 24.000 | ||
| Hatfield Jeffrey S. | 24.000 | ||
| Hughes Thomas E. Director - [D] | 12.827 | 855 | |
| Kristian Humer | 90.000 | ||
| Robert Brian Johnson | 0 | ||
| Kevin Koch | 24.000 | ||
| Barrett Katz Chief Medical Officer - [O] | 0 | 0 | |
| Tomas Kiselak | 24.000 | ||
|
Peter Kolchinsky
10% Owner -
|
410.686 | 410.686 | |
|
Alpha, Lllp Lebow
10% Owner -
|
4.465.258 | 4.465.258 | |
|
Bennett S Lebow
Director, 10% Owner -
[D]
|
280.600 | 18.707 | |
| Kyle Lefkoff Director - [D] | 463.473 | 30.898 | |
| Leverone Jason A. CFO, Treasurer & Secretary - [O] | 48.829 | 3.255 | |
| Adam Scott Levy Chief Business Officer - [O] | 10.540 | 703 | |
|
Logos Global Master Fund LP
10% Owner -
|
550.000 | 550.000 | |
| Mahoney Stephen F. President and CEO, Director - [D] [O] | 33.349 | 33.349 | |
| William Stuart Marshall President & CEO, Director - [D] [O] | 270.646 | 18.043 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Lara Meisner Chief Legal Officer - [O] | 29.971 | 29.971 | |
| Arlene Morris | 24.000 | ||
| Scott Dunseth Myers Chief Executive Officer, Director - [D] [O] | 259.500 | 259.500 | |
|
Point72 Asset Management, L.P.
10% Owner -
|
426.162 | 426.162 | |
|
Point72 Capital Advisors, Inc.
10% Owner -
|
426.162 | 426.162 | |
|
Ra Capital Management, Llc
10% Owner -
|
410.686 | 410.686 | |
|
RA Capital Healthcare Fund LP
10% Owner -
|
410.686 | 410.686 | |
| Paul D Rubin | 87.000 | ||
| Rauch Lee M. | 900.000 | ||
|
Remeditex Ventures LLC
10% Owner -
|
5.413.126 | 360.875 | |
| Samuel D Riccitelli President & CEO, Director - [D] [O] | 571.370 | 571.370 | |
| Tamara A Seymour CFO, Secretary, Treasurer - [O] | 106.447 | 106.447 | |
| Douglas A Schuling Director - [D] | 10.500 | 10.500 | |
|
Shah Rajeev M.
10% Owner -
|
410.686 | 410.686 | |
| Robin L Smith Director - [D] | 1.900 | 1.900 | |
| Joseph L Turner | 24.000 | ||
| Jennifer Tousignant Chief Legal Officer - [O] | 3.494 | 3.494 | |
| Jonathan Violin Chief Executive Officer, Director - [D] [O] | 480.905 | 480.905 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i VRDN / Viridian Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i VRDN / Viridian Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-09 | 2026-03-03 | 4/A | Harmon Seth | VRDN | Common Stock | D | 30,1900 | -2.031 | -61 | 7.850 | ||||
| 2026-03-09 | 2026-03-03 | 4/A | Beetham Thomas W. | VRDN | Common Stock | D | 30,1900 | -3.048 | -92 | 13.361 | ||||
| 2026-03-09 | 2026-03-03 | 4/A | Mahoney Stephen F. | VRDN | Common Stock | D | 30,1900 | -7.408 | -224 | 33.349 | ||||
| 2026-03-09 | 2026-03-03 | 4/A | Tousignant Jennifer | VRDN | Common Stock | D | 30,1900 | -1.675 | -51 | 3.494 | ||||
| 2026-03-04 | 2026-03-03 | 4 | Tousignant Jennifer | VRDN | Common Stock | D | 29,3200 | -1.724 | -51 | 3.445 | ||||
| 2026-03-04 | 2026-03-03 | 4 | Tousignant Jennifer | VRDN | Common Stock | D | 5.169 | 5.169 | ||||||
| 2026-03-04 | 2026-03-03 | 4 | Harmon Seth | VRDN | Common Stock | D | 29,3200 | -2.091 | -61 | 7.790 | ||||
| 2026-03-04 | 2026-03-03 | 4 | Harmon Seth | VRDN | Common Stock | D | 6.267 | 9.881 | ||||||
| 2026-03-04 | 2026-03-03 | 4 | Beetham Thomas W. | VRDN | Common Stock | D | 29,3200 | -3.138 | -92 | 13.271 | ||||
| 2026-03-04 | 2026-03-03 | 4 | Beetham Thomas W. | VRDN | Common Stock | D | 9.409 | 16.409 | ||||||
| 2026-03-04 | 2026-03-03 | 4 | Mahoney Stephen F. | VRDN | Common Stock | D | 29,3200 | -7.627 | -224 | 33.130 | ||||
| 2026-03-04 | 2026-03-03 | 4 | Mahoney Stephen F. | VRDN | Common Stock | D | 18.357 | 40.757 | ||||||
| 2026-01-02 | 2025-12-31 | 4 | Tousignant Jennifer | VRDN | Common Stock | D | 31,1600 | -2.272 | -71 | 0 | ||||
| 2025-10-27 | 2025-10-23 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 22,0000 | 454.545 | 10.000 | 3.914.458 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 12,3100 | 12.500 | 154 | 3.459.913 | ||||
| 2025-06-11 | 2025-06-09 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 7,8000 | 1.600 | 12 | 3.447.413 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Beetham Thomas W. | VRDN | Common Stock | D | 23,4100 | 5.000 | 117 | 6.000 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Mahoney Stephen F. | VRDN | Common Stock | D | 23,3300 | 21.400 | 499 | 21.400 | ||||
| 2024-09-17 | 2024-09-13 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 18,7500 | 1.600.000 | 30.000 | 3.445.813 | ||||
| 2024-04-01 | 2024-03-28 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 5.859 | 1.845.813 | ||||||
| 2024-04-01 | 2024-03-28 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | VRDN | Common Stock | I | -5.859 | 0 | ||||||
| 2024-01-24 | 2024-01-22 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 21,0000 | 476.190 | 10.000 | 1.839.954 | ||||
| 2024-01-12 | 3 | Ciulla Thomas | VRDN | Common Stock | D | 762 | ||||||||
| 2023-06-20 | 2023-06-16 | 4 | Meisner Lara | VRDN | Common Stock | D | 28,3500 | -27 | -1 | 29.971 | ||||
| 2023-06-20 | 2023-06-16 | 4 | Meisner Lara | VRDN | Common Stock | D | 23,0300 | 27 | 1 | 29.998 | ||||
| 2023-06-20 | 2023-06-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 28,0200 | -2.269 | -64 | 29.971 | ||||
| 2023-06-20 | 2023-06-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 23,0300 | 2.269 | 52 | 32.240 | ||||
| 2023-06-06 | 2023-06-06 | 4 | Meisner Lara | VRDN | Common Stock | D | 25,0200 | -5.126 | -128 | 29.971 | ||||
| 2023-06-06 | 2023-06-06 | 4 | Meisner Lara | VRDN | Common Stock | D | 18,5100 | 5.126 | 95 | 35.097 | ||||
| 2023-06-06 | 2023-06-05 | 4 | Meisner Lara | VRDN | Common Stock | D | 25,0300 | -499 | -12 | 29.971 | ||||
| 2023-06-06 | 2023-06-05 | 4 | Meisner Lara | VRDN | Common Stock | D | 18,5100 | 499 | 9 | 30.470 | ||||
| 2023-06-06 | 2023-06-02 | 4 | Meisner Lara | VRDN | Common Stock | D | 24,2100 | -1.875 | -45 | 29.971 | ||||
| 2023-06-06 | 2023-06-02 | 4 | Meisner Lara | VRDN | Common Stock | D | 14,0000 | 1.875 | 26 | 31.846 | ||||
| 2023-04-12 | 2023-04-12 | 4 | Myers Scott Dunseth | VRDN | Common Stock | D | 25,3697 | 4.000 | 101 | 259.500 | ||||
| 2023-03-13 | 2023-03-13 | 4 | Myers Scott Dunseth | VRDN | Common Stock | D | 29,1499 | 5.500 | 160 | 255.500 | ||||
| 2023-03-10 | 2023-03-09 | 4 | Meisner Lara | VRDN | Common Stock | D | 29,0700 | -29.971 | -871 | 0 | ||||
| 2023-02-07 | 2023-02-06 | 4 | Myers Scott Dunseth | VRDN | Common Stock | D | 250.000 | 250.000 | ||||||
| 2023-02-07 | 2023-02-02 | 4/A | Violin Jonathan | VRDN | Common Stock | D | 36,8000 | -50.000 | -1.840 | 480.905 | ||||
| 2023-02-07 | 2023-02-02 | 4/A | Violin Jonathan | VRDN | Common Stock | D | 0,1500 | 50.000 | 8 | 530.905 | ||||
| 2023-02-03 | 2023-02-02 | 4 | Violin Jonathan | VRDN | Common Stock | D | 36,8000 | -50.000 | -1.840 | 430.905 | ||||
| 2023-01-25 | 2023-01-23 | 4 | Meisner Lara | VRDN | Common Stock | D | 35,6600 | -6.843 | -244 | 0 | ||||
| 2023-01-25 | 2023-01-23 | 4 | Meisner Lara | VRDN | Common Stock | D | 14,0000 | 1.872 | 26 | 6.843 | ||||
| 2023-01-25 | 2023-01-23 | 4 | Meisner Lara | VRDN | Common Stock | D | 23,0300 | 4.971 | 114 | 4.971 | ||||
| 2023-01-18 | 2023-01-17 | 4 | Katz Barrett | VRDN | Common Stock | D | 37,2100 | -24.853 | -925 | 0 | ||||
| 2023-01-18 | 2023-01-17 | 4 | Katz Barrett | VRDN | Common Stock | D | 23,0300 | 24.853 | 572 | 24.853 | ||||
| 2023-01-18 | 2023-01-13 | 4 | Katz Barrett | VRDN | Common Stock | D | 37,0100 | -4.147 | -153 | 0 | ||||
| 2023-01-18 | 2023-01-13 | 4 | Katz Barrett | VRDN | Common Stock | D | 23,0300 | 4.147 | 96 | 4.147 | ||||
| 2023-01-11 | 2023-01-10 | 4 | Katz Barrett | VRDN | Common Stock | D | 35,3000 | -47.377 | -1.672 | 0 | ||||
| 2023-01-11 | 2023-01-10 | 4 | Katz Barrett | VRDN | Common Stock | D | 23,0300 | 47.377 | 1.091 | 47.377 | ||||
| 2023-01-11 | 2023-01-09 | 4 | Katz Barrett | VRDN | Common Stock | D | 33,0400 | -12.623 | -417 | 0 | ||||
| 2023-01-11 | 2023-01-09 | 4 | Katz Barrett | VRDN | Common Stock | D | 23,0300 | 12.623 | 291 | 12.623 | ||||
| 2022-12-22 | 2022-12-21 | 4 | Meisner Lara | VRDN | Common Stock | D | 29,1900 | -16.326 | -477 | 0 | ||||
| 2022-12-22 | 2022-12-21 | 4 | Meisner Lara | VRDN | Common Stock | D | 23,0300 | 16.326 | 376 | 16.326 | ||||
| 2022-12-22 | 2022-12-20 | 4 | Meisner Lara | VRDN | Common Stock | D | 28,0700 | -600 | -17 | 0 | ||||
| 2022-12-22 | 2022-12-20 | 4 | Meisner Lara | VRDN | Common Stock | D | 23,0300 | 600 | 14 | 600 | ||||
| 2022-12-19 | 2022-12-16 | 4 | Meisner Lara | VRDN | Common Stock | D | 28,4400 | -1.297 | -37 | 0 | ||||
| 2022-12-19 | 2022-12-16 | 4 | Meisner Lara | VRDN | Common Stock | D | 23,0300 | 1.297 | 30 | 1.297 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 28,0800 | -300 | -8 | 0 | ||||
| 2022-12-19 | 2022-12-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 23,0300 | 300 | 7 | 300 | ||||
| 2022-12-14 | 2022-12-14 | 4 | Meisner Lara | VRDN | Common Stock | D | 28,1200 | -15.656 | -440 | 0 | ||||
| 2022-12-14 | 2022-12-14 | 4 | Meisner Lara | VRDN | Common Stock | D | 23,0300 | 15.656 | 361 | 15.656 | ||||
| 2022-12-14 | 2022-12-12 | 4 | Meisner Lara | VRDN | Common Stock | D | 28,0500 | -600 | -17 | 0 | ||||
| 2022-12-14 | 2022-12-12 | 4 | Meisner Lara | VRDN | Common Stock | D | 23,0300 | 600 | 14 | 600 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 22,0500 | -8.125 | -179 | 0 | ||||
| 2022-11-16 | 2022-11-15 | 4 | Meisner Lara | VRDN | Common Stock | D | 14,0000 | 8.125 | 114 | 8.125 | ||||
| 2022-08-19 | 2022-08-17 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 23,5000 | 425.531 | 10.000 | 1.363.764 | ||||
| 2022-06-02 | 2022-06-01 | 4 | Violin Jonathan | VRDN | Common Stock | D | 12,2000 | -30.000 | -366 | 480.905 | ||||
| 2022-05-04 | 2022-05-02 | 4 | Violin Jonathan | VRDN | Common Stock | D | 13,0400 | -30.000 | -391 | 510.905 | ||||
| 2022-04-05 | 2022-04-04 | 4 | Violin Jonathan | VRDN | Common Stock | D | 18,9300 | -3.600 | -68 | 540.905 | ||||
| 2022-04-05 | 2022-04-01 | 4 | Violin Jonathan | VRDN | Common Stock | D | 18,9200 | -26.400 | -499 | 544.505 | ||||
| 2022-03-03 | 2022-03-02 | 4 | Violin Jonathan | VRDN | Common Stock | D | 17,3600 | -11.106 | -193 | 570.905 | ||||
| 2022-03-03 | 2022-03-01 | 4 | Violin Jonathan | VRDN | Common Stock | D | 17,8200 | -18.894 | -337 | 582.011 | ||||
| 2022-02-03 | 2022-02-02 | 4 | Humer Kristian | VRDN | Stock Option (Right to Buy) | D | 18,51 | 90.000 | 90.000 | |||||
| 2022-02-03 | 2022-02-02 | 4 | Katz Barrett | VRDN | Stock Option (Right to Buy) | D | 18,51 | 110.000 | 110.000 | |||||
| 2022-02-03 | 2022-02-02 | 4 | Meisner Lara | VRDN | Stock Option (Right to Buy) | D | 18,51 | 90.000 | 90.000 | |||||
| 2022-02-03 | 2022-02-03 | 4 | Violin Jonathan | VRDN | Common Stock | D | 19,1600 | -909 | -17 | 600.905 | ||||
| 2022-02-03 | 2022-02-02 | 4 | Violin Jonathan | VRDN | Stock Option (Right to Buy) | D | 18,51 | 280.000 | 280.000 | |||||
| 2022-02-03 | 2022-02-02 | 4 | Violin Jonathan | VRDN | Common Stock | D | 18,4700 | -12.340 | -228 | 601.814 | ||||
| 2022-02-03 | 2022-02-01 | 4 | Violin Jonathan | VRDN | Common Stock | D | 19,5500 | -16.751 | -327 | 614.154 | ||||
| 2022-01-03 | 2021-12-31 | 4 | Humer Kristian | VRDN | Stock Option (Right to Buy) | D | 19,77 | 121.371 | 121.371 | |||||
| 2021-12-10 | 2021-12-08 | 4 | Violin Jonathan | VRDN | Series A Non-Voting Convertible Preferred Stock | D | -9.413 | 0 | ||||||
| 2021-12-10 | 2021-12-08 | 4 | Violin Jonathan | VRDN | Common Stock | D | 627.564 | 630.905 | ||||||
| 2021-09-28 | 2021-09-23 | 4 | Frazier Life Sciences Public Fund, L.P. | VRDN | Common Stock | D | 11,0000 | 200.000 | 2.200 | 1.505.200 | ||||
| 2021-09-23 | 2021-09-21 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | VRDN | Common Stock | I | 11,0000 | 909.000 | 9.999 | 938.233 | ||||
| 2021-08-26 | 3 | FHMLSP, L.P. | VRDN | Common Stock | D | 1.305.200 | ||||||||
| 2021-07-27 | 2021-07-26 | 4 | Humer Kristian | VRDN | Stock Option (Right to Buy) | D | 17,09 | 360.000 | 360.000 | |||||
| 2021-07-15 | 2021-07-14 | 4 | Moses Jennifer K. | VRDN | Stock Option (Right to Buy) | D | 17,88 | 25.000 | 25.000 | |||||
| 2021-06-16 | 2021-06-03 | 4 | Kiselak Tomas | VRDN | Stock Option (Right to Buy) | D | 16,60 | 12.500 | 12.500 | |||||
| 2021-06-16 | 2021-06-03 | 4 | Harwin Peter Evan | VRDN | Stock Option (Right to Buy) | D | 16,60 | 12.500 | 12.500 | |||||
| 2021-06-16 | 2021-06-03 | 4 | Morris Arlene | VRDN | Stock Option (Right to Buy) | D | 16,60 | 12.500 | 12.500 | |||||
| 2021-02-08 | 2021-02-04 | 4 | TURNER JOSEPH L | VRDN | Director Stock Option (Right to Buy) | D | 20,50 | 25.000 | 25.000 | |||||
| 2021-02-08 | 2021-02-04 | 4 | Harwin Peter Evan | VRDN | Director Stock Option (Right to Buy) | D | 20,50 | 25.000 | 25.000 | |||||
| 2021-02-08 | 2021-02-04 | 4 | Hatfield Jeffrey S. | VRDN | Director Stock Option (Right to Buy) | D | 20,50 | 25.000 | 25.000 | |||||
| 2021-02-08 | 2021-02-04 | 4 | Kiselak Tomas | VRDN | Director Stock Option (Right to Buy) | D | 20,50 | 25.000 | 25.000 | |||||
| 2021-02-08 | 2021-02-04 | 4 | Morris Arlene | VRDN | Director Stock Option (Right to Buy) | D | 20,50 | 25.000 | 25.000 | |||||
| 2021-01-21 | 2021-01-18 | 4 | Katz Barrett | VRDN | Employee Stock Option (right to buy) | D | 23,03 | 356.000 | 356.000 | |||||
| 2021-01-20 | 2021-01-18 | 4 | Leverone Jason A. | VRDN | Employee Stock Option (right to buy) | D | 23,03 | 311.785 | 311.785 | |||||
| 2021-01-20 | 2021-01-18 | 4 | Violin Jonathan | VRDN | Employee Stock Option (right to buy) | D | 23,03 | 800.075 | 800.075 | |||||
| 2021-01-19 | 2021-01-18 | 4 | Rauch Lee M. | MGEN | Employee Stock Option (right to buy) | D | 23,03 | 15.000 | 15.000 | |||||
| 2020-12-17 | 3 | Shah Rajeev M. | MGEN | Common Stock | I | 410.686 | ||||||||
| 2020-11-20 | 3 | COHEN STEVEN A/SAC CAPITAL MGMT LP See footnotes | MGEN | Common Stock | I | 426.162 | ||||||||
| 2020-11-16 | 2020-11-13 | 4 | Logos Global Master Fund LP | MGEN | Common Stock | D | 14,8389 | 126.667 | 1.880 | 550.000 | ||||
| 2020-11-16 | 2020-11-09 | 4 | Logos Global Master Fund LP | MGEN | Common Stock | D | 1,1641 | 100.000 | 116 | 6.350.000 | ||||
| 2020-11-16 | 2020-11-09 | 4 | Logos Global Master Fund LP | MGEN | Common Stock | D | 1,0979 | 250.000 | 274 | 6.250.000 | ||||
| 2020-11-16 | 3 | Logos Global Master Fund LP | MGEN | Common Stock | D | 6.000.000 | ||||||||
| 2020-10-30 | 2020-10-27 | 4 | Violin Jonathan | MGEN | Series A Non-Voting Convertible Preferred Stock | D | 9.413 | 9.413 | ||||||
| 2020-10-30 | 2020-10-27 | 4 | Violin Jonathan | MGEN | Employee Stock Option (Right to Buy) | D | 0,01 | 4.338.079 | 4.338.079 | |||||
| 2020-10-30 | 2020-10-27 | 4 | Violin Jonathan | MGEN | Common Stock | D | 50.124 | 50.124 | ||||||
| 2020-10-30 | 3 | Violin Jonathan | MGEN | Common Stock | D | 50.124 | ||||||||
| 2020-10-30 | 2020-10-30 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | MGEN | Series A Non-Voting Convertible Preferred Stock | I | 465,9600 | 28.843 | 13.440 | 111.192 | ||||
| 2020-10-30 | 2020-10-30 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | MGEN | Series A Non-Voting Convertible Preferred Stock | I | 465,9600 | 5.494 | 2.560 | 21.999 | ||||
| 2020-10-30 | 3 | Fairmount Healthcare Fund II L.P. By funds | MGEN | Common Stock | I | 526.393 | ||||||||
| 2020-10-29 | 2020-10-27 | 4 | Kiselak Tomas | MGEN | Director Stock Option (Right to Buy) | D | 0,52 | 24.000 | 24.000 | |||||
| 2020-10-29 | 2020-10-27 | 4 | Harwin Peter Evan | MGEN | Director Stock Option (Right to Buy) | D | 0,52 | 24.000 | 24.000 | |||||
| 2020-10-29 | 2020-10-27 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | MGEN | Series A Non-Voting Convertible Preferred Stock | I | 82.349 | 82.349 | ||||||
| 2020-10-29 | 2020-10-27 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | MGEN | Series A Non-Voting Convertible Preferred Stock | I | 16.505 | 16.505 | ||||||
| 2020-10-29 | 2020-10-27 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund II LP | MGEN | Common Stock | I | 438.502 | 438.502 | ||||||
| 2020-10-29 | 2020-10-27 | 4 | Fairmount Funds Management LLC Fairmount Healthcare Fund LP | MGEN | Common Stock | I | 87.891 | 87.891 | ||||||
| 2020-09-17 | 2020-09-13 | 4/A | Rauch Lee M. | MGEN | Stock Option (right to buy) | D | 0,91 | 900.000 | 900.000 | |||||
| 2020-09-15 | 2020-09-14 | 4 | Rauch Lee M. | MGEN | Stock Option (right to buy) | D | 0,91 | 900.000 | 900.000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Hatfield Jeffrey S. | MGEN | Stock Option (right to buy) | D | 0,63 | 24.000 | 24.000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | TURNER JOSEPH L | MGEN | Stock Option (right to buy) | D | 0,63 | 24.000 | 24.000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 0,63 | 24.000 | 24.000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | KOCH KEVIN | MGEN | Stock Option (right to buy) | D | 0,63 | 24.000 | 24.000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Morris Arlene | MGEN | Stock Option (right to buy) | D | 0,63 | 24.000 | 24.000 | |||||
| 2020-05-22 | 2020-05-21 | 4 | Bowden Christopher | MGEN | Stock Option (right to buy) | D | 0,63 | 24.000 | 24.000 | |||||
| 2020-03-17 | 2020-03-13 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 0,57 | -11.249 | 0 | |||||
| 2020-03-17 | 2020-03-13 | 4 | Leverone Jason A. | MGEN | Common Stock | D | 0,5700 | 11.249 | 6 | 48.829 | ||||
| 2020-02-14 | 2020-02-12 | 4 | Marshall William Stuart | MGEN | Stock Option (right to buy) | D | 0,80 | 464.000 | 464.000 | |||||
| 2020-02-14 | 2020-02-12 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 0,80 | 185.000 | 185.000 | |||||
| 2020-02-14 | 2020-02-12 | 4 | Escolar Diana | MGEN | Stock Option (right to buy) | D | 0,80 | 270.000 | 270.000 | |||||
| 2020-02-13 | 2019-08-21 | 5 | Marshall William Stuart | MGEN | Common Stock | D | 1,1390 | 1.250 | 1 | 270.646 | ||||
| 2020-02-13 | 2019-02-21 | 5 | Marshall William Stuart | MGEN | Common Stock | D | 2,4565 | 1.250 | 3 | 269.396 | ||||
| 2019-08-23 | 2019-08-23 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 0,57 | -3.093 | 0 | |||||
| 2019-08-23 | 2019-08-23 | 4 | Leverone Jason A. | MGEN | Common Stock | D | 0,5700 | 3.093 | 2 | 36.330 | ||||
| 2019-06-21 | 2019-06-19 | 4 | Bowden Christopher | MGEN | Stock Option (right to buy) | D | 2,36 | 12.000 | 12.000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Hatfield Jeffrey S. | MGEN | Stock Option (right to buy) | D | 2,36 | 12.000 | 12.000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 2,36 | 12.000 | 12.000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | KOCH KEVIN | MGEN | Stock Option (right to buy) | D | 2,36 | 12.000 | 12.000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | Morris Arlene | MGEN | Stock Option (right to buy) | D | 2,36 | 12.000 | 12.000 | |||||
| 2019-06-21 | 2019-06-19 | 4 | TURNER JOSEPH L | MGEN | Stock Option (right to buy) | D | 2,36 | 12.000 | 12.000 | |||||
| 2019-04-05 | 2019-04-03 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 2,99 | 10.106 | 10.106 | |||||
| 2019-02-08 | 2019-02-06 | 4 | Marshall William Stuart | MGEN | Stock Option (right to buy) | D | 2,96 | 232.000 | 232.000 | |||||
| 2019-02-08 | 2019-02-06 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 2,96 | 75.000 | 75.000 | |||||
| 2019-02-08 | 2019-02-06 | 4 | Levy Adam Scott | MGEN | Stock Option (right to buy) | D | 2,96 | 74.000 | 74.000 | |||||
| 2019-02-08 | 2019-02-06 | 4 | RUBIN PAUL D | MGEN | Stock Option (right to buy) | D | 2,96 | 87.000 | 87.000 | |||||
| 2018-10-12 | 2018-10-11 | 4 | Hughes Thomas E. | MGEN | Common Stock | D | 4,7697 | 10.000 | 48 | 12.827 | ||||
| 2018-08-09 | 2018-08-07 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 0,57 | -29.530 | 0 | |||||
| 2018-08-09 | 2018-08-07 | 4 | Leverone Jason A. | MGEN | Common Stock | D | 0,5700 | 29.530 | 17 | 30.737 | ||||
| 2018-06-28 | 2018-06-27 | 4 | Morris Arlene | MGEN | Stock Option (right to buy) | D | 6,46 | 12.000 | 12.000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | TURNER JOSEPH L | MGEN | Stock Option (right to buy) | D | 6,46 | 12.000 | 12.000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | Booth Bruce | MGEN | Stock Option (right to buy) | D | 6,46 | 12.000 | 12.000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | Bowden Christopher | MGEN | Stock Option (right to buy) | D | 6,46 | 12.000 | 12.000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | Hatfield Jeffrey S. | MGEN | Stock Option (right to buy) | D | 6,46 | 12.000 | 12.000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 6,46 | 12.000 | 12.000 | |||||
| 2018-06-28 | 2018-06-27 | 4 | KOCH KEVIN | MGEN | Stock Option (right to buy) | D | 6,46 | 12.000 | 12.000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Marshall William Stuart | MGEN | Stock Option (right to buy) | D | 0,57 | -115.818 | 0 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Marshall William Stuart | MGEN | Common Stock | D | 0,5700 | 115.818 | 66 | 265.646 | ||||
| 2018-02-13 | 2018-02-13 | 4 | Booth Bruce | MGEN | Common Stock | I | 5,5000 | 545.454 | 3.000 | 1.351.090 | ||||
| 2018-02-13 | 2018-02-13 | 4 | Levy Adam Scott | MGEN | Common Stock | D | 5,5000 | 9.090 | 50 | 10.540 | ||||
| 2018-02-02 | 2018-01-31 | 4 | Marshall William Stuart | MGEN | Stock Option (right to buy) | D | 7,50 | 245.000 | 245.000 | |||||
| 2018-02-02 | 2018-01-31 | 4 | RUBIN PAUL D | MGEN | Stock Option (right to buy) | D | 7,50 | 85.000 | 85.000 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Levy Adam Scott | MGEN | Stock Option (right to buy) | D | 7,50 | 80.000 | 80.000 | |||||
| 2018-02-02 | 2018-01-31 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 7,50 | 75.000 | 75.000 | |||||
| 2018-01-05 | 2018-01-03 | 4 | Booth Bruce | MGEN | Stock Option (right to buy) | D | 9,72 | 10.191 | 10.191 | |||||
| 2018-01-05 | 2018-01-03 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 9,72 | 3.426 | 3.426 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Hughes Thomas E. | MGEN | Common Stock | D | 8,0000 | -12.000 | -96 | 2.827 | ||||
| 2017-06-30 | 2017-06-28 | 4 | KOCH KEVIN | MGEN | Stock Option (right to buy) | D | 12,06 | 12.000 | 12.000 | |||||
| 2017-06-30 | 2017-06-28 | 4 | LEFKOFF KYLE | MGEN | Stock Option (right to buy) | D | 12,06 | 12.000 | 12.000 | |||||
| 2017-06-30 | 2017-06-28 | 4 | Booth Bruce | MGEN | Stock Option (right to buy) | D | 12,06 | 12.000 | 12.000 | |||||
| 2017-06-30 | 2017-06-28 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 12,06 | 12.000 | 12.000 | |||||
| 2017-06-30 | 2017-06-28 | 4 | Creecy John W | MGEN | Stock Option (right to buy) | D | 12,06 | 12.000 | 12.000 | |||||
| 2017-06-30 | 2017-06-28 | 4 | TURNER JOSEPH L | MGEN | Stock Option (right to buy) | D | 12,06 | 12.000 | 12.000 | |||||
| 2017-06-23 | 2017-06-22 | 4 | Levy Adam Scott | MGEN | Common Stock | D | 7,5500 | 200 | 2 | 200 | ||||
| 2017-03-28 | 2017-03-24 | 4 | Booth Bruce | MGEN | Stock Option (right to buy) | D | 11,80 | 6.844 | 6.844 | |||||
| 2017-03-28 | 2017-03-24 | 4 | Hughes Thomas E. | MGEN | Stock Option (right to buy) | D | 11,80 | 1.191 | 1.191 | |||||
| 2017-03-28 | 2017-03-24 | 4 | Hughes Thomas E. | MGEN | Common Stock | D | 778 | 14.840 | ||||||
| 2017-03-13 | 2017-03-10 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 14,3118 | -3.300 | -47 | 463.473 | ||||
| 2017-03-13 | 2017-03-09 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 14,3846 | -2.500 | -36 | 466.773 | ||||
| 2017-03-08 | 2017-03-08 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 14,7028 | -5.000 | -74 | 469.273 | ||||
| 2017-03-08 | 2017-03-06 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 16,2398 | -608 | -10 | 474.273 | ||||
| 2017-03-08 | 2017-03-06 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 15,7144 | -9.392 | -148 | 474.881 | ||||
| 2017-02-28 | 2017-02-28 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 13,5430 | -2.258 | -31 | 484.273 | ||||
| 2017-02-28 | 2017-02-27 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 13,7910 | -1.500 | -21 | 486.531 | ||||
| 2017-02-28 | 2017-02-24 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 14,0388 | -6.500 | -91 | 488.031 | ||||
| 2017-02-24 | 2017-02-23 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 13,6477 | -1.800 | -25 | 494.531 | ||||
| 2017-02-24 | 2017-02-22 | 4 | LEFKOFF KYLE | MGEN | Common Stock | I | 14,3554 | -4.102 | -59 | 496.331 | ||||
| 2017-02-16 | 2017-02-16 | 4 | RUBIN PAUL D | MGEN | Stock Option (right to buy) | D | 11,01 | 87.500 | 87.500 | |||||
| 2017-02-16 | 2017-02-16 | 4 | Leverone Jason A. | MGEN | Stock Option (right to buy) | D | 11,01 | 77.500 | 77.500 | |||||
| 2017-02-16 | 2017-02-16 | 4 | Marshall William Stuart | MGEN | Stock Option (right to buy) | D | 11,01 | 200.000 | 200.000 | |||||
| 2017-02-16 | 2017-02-16 | 4 | Levy Adam Scott | MGEN | Stock Option (right to buy) | D | 11,01 | 87.500 | 87.500 | |||||
| 2017-02-13 | 3 | Creecy John W | MGEN | Common Stock | I | 5.413.126 | ||||||||
| 2017-02-13 | 3 | Creecy John W | MGEN | Common Stock | I | 5.413.126 | ||||||||
| 2017-02-13 | 3 | Remeditex Ventures LLC | MGEN | Common Stock | D | 5.413.126 | ||||||||
| 2017-02-13 | 3 | Remeditex Ventures LLC | MGEN | Common Stock | D | 5.413.126 | ||||||||
| 2017-02-13 | 3 | Atlas Venture Fund VII L P | MGEN | Common Stock | D | 6.285.160 | ||||||||
| 2017-02-13 | 3 | Atlas Venture Fund VII L P | MGEN | Common Stock | D | 6.285.160 | ||||||||
| 2017-02-13 | 3 | LEFKOFF KYLE See Footnotes | MGEN | Common Stock | I | 3.715.307 | ||||||||
| 2017-02-13 | 3 | LEFKOFF KYLE See Footnotes | MGEN | Common Stock | I | 2.608.303 | ||||||||
| 2017-02-13 | 3 | LEFKOFF KYLE See Footnotes | MGEN | Common Stock | I | 3.715.307 | ||||||||
| 2017-02-13 | 3 | LEFKOFF KYLE See Footnotes | MGEN | Common Stock | I | 2.608.303 | ||||||||
| 2017-02-13 | 3 | Marshall William Stuart | MGEN | Common Stock | D | 297.156 | ||||||||
| 2017-02-13 | 3 | Marshall William Stuart | MGEN | Common Stock | D | 297.156 | ||||||||
| 2017-02-13 | 3 | Booth Bruce | MGEN | Common Stock | I | 7.090.796 | ||||||||
| 2017-02-13 | 3 | Booth Bruce | MGEN | Common Stock | I | 4.753.852 | ||||||||
| 2017-02-13 | 3 | Booth Bruce | MGEN | Common Stock | I | 7.090.796 | ||||||||
| 2017-02-13 | 3 | Booth Bruce | MGEN | Common Stock | I | 4.753.852 | ||||||||
| 2017-02-13 | 3 | Hughes Thomas E. | MGEN | Common Stock | D | 28.124 | ||||||||
| 2017-02-13 | 3 | Hughes Thomas E. | MGEN | Common Stock | D | 28.124 | ||||||||
| 2017-02-13 | 2017-02-13 | 4 | LEBOW BENNETT S | MGEN | Unsecured Demand Promissory Note | D | 5,39 | 0 | ||||||
| 2017-02-13 | 2017-02-13 | 4 | LEBOW BENNETT S | MGEN | Unsecured Demand Promissory Note | D | 5,39 | |||||||
| 2017-02-13 | 2017-02-13 | 4 | LEBOW BENNETT S | MGEN | Common Stock | D | 5,3900 | 279.067 | 1.504 | 280.600 | ||||
| 2017-02-08 | 2017-02-08 | 4 | Gonyer David A | SGNL | Stock Option (Right to Buy) | D | 7,65 | -1.200 | 0 | |||||
| 2017-02-08 | 2017-02-08 | 4 | Gonyer David A | SGNL | Common Stock | D | 7,6500 | 1.200 | 9 | 1.899 | ||||
| 2017-02-07 | 2017-02-03 | 4 | Smith Robin L | SGNL | Stock Option (Right to Buy) | D | 7,65 | -1.200 | 0 | |||||
| 2017-02-07 | 2017-02-03 | 4 | Smith Robin L | SGNL | Common Stock | D | 7,6500 | 1.200 | 9 | 1.900 | ||||
| 2017-02-07 | 2017-02-03 | 4 | LEBOW BENNETT S | SGNL | Stock Option (Right to Buy) | D | 7,65 | -1.200 | 0 | |||||
| 2017-02-07 | 2017-02-03 | 4 | LEBOW BENNETT S | SGNL | Common Stock | D | 7,6500 | 1.200 | 9 | 1.533 | ||||
| 2016-11-02 | 2016-10-31 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | 0,00 | -200.000 | 0 | |||||
| 2016-11-02 | 2016-10-31 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 0,3600 | -103.160 | -37 | 571.370 | ||||
| 2016-11-02 | 2016-10-31 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 200.000 | 674.530 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | -100.000 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | -46.000 | 0 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 0,3600 | -45.580 | -16 | 106.447 | ||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 100.000 | 152.027 | ||||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 0,3600 | -20.967 | -8 | 52.027 | ||||
| 2016-11-02 | 2016-10-31 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 46.000 | 72.994 | ||||||
| 2016-08-10 | 2016-08-08 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | -23.000 | 46.000 | ||||||
| 2016-08-10 | 2016-08-08 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 0,4850 | -10.484 | -5 | 26.994 | ||||
| 2016-08-10 | 2016-08-08 | 4 | SEYMOUR TAMARA A By Trust | SGNL | Common Stock | I | 23.000 | 37.478 | ||||||
| 2016-06-30 | 2016-06-28 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | 0,00 | -124.251 | 0 | |||||
| 2016-06-30 | 2016-06-28 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 0,4600 | -64.835 | -30 | 474.530 | ||||
| 2016-06-30 | 2016-06-28 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 124.251 | 539.365 | ||||||
| 2016-06-20 | 2016-06-15 | 4 | Gonyer David A | SGNL | Stock Option (Right to Buy) | D | 0,51 | 18.000 | 18.000 | |||||
| 2016-06-20 | 2016-06-15 | 4 | Schuling Douglas A | SGNL | Stock Option (Right to Buy) | D | 0,51 | 18.000 | 18.000 | |||||
| 2016-06-20 | 2016-06-15 | 4 | Smith Robin L | SGNL | Stock Option (Right to Buy) | D | 0,51 | 18.000 | 18.000 | |||||
| 2016-06-20 | 2016-06-15 | 4 | LEBOW BENNETT S | SGNL | Stock Option (Right to Buy) | D | 0,51 | 18.000 | 18.000 | |||||
| 2016-05-19 | 2016-03-28 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | 0,00 | 200.000 | 200.000 | |||||
| 2016-05-19 | 2016-03-28 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | 0,00 | 100.000 | 100.000 | |||||
| 2016-02-12 | 2016-02-11 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | 0,00 | -124.252 | 124.251 | |||||
| 2016-02-12 | 2016-02-11 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 0,4600 | -54.268 | -25 | 415.114 | ||||
| 2016-02-12 | 2016-02-11 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 124.252 | 469.382 | ||||||
| 2015-11-23 | 2015-11-20 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 0,8000 | 7.000 | 6 | 345.130 | ||||
| 2015-11-23 | 2015-11-19 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 0,7800 | 7.000 | 5 | 338.130 | ||||
| 2015-08-14 | 2015-08-12 | 4 | SEYMOUR TAMARA A | SGNL | Employee Stock Option (Right to Buy) | D | 1,57 | 60.000 | 60.000 | |||||
| 2015-08-10 | 2015-08-06 | 4 | Gonyer David A | SGNL | Stock Option (Right to Buy) | D | 1,62 | 18.000 | 18.000 | |||||
| 2015-08-10 | 2015-08-06 | 4 | Gonyer David A | SGNL | Restricted Stock Units | D | -4.125 | 0 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Gonyer David A | SGNL | Common Stock | D | 5.000 | 10.500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Gonyer David A | SGNL | Common Stock | D | 4.125 | 5.500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Schuling Douglas A | SGNL | Stock Option (Right to Buy) | D | 1,62 | 18.000 | 18.000 | |||||
| 2015-08-10 | 2015-08-06 | 4 | Schuling Douglas A | SGNL | Restricted Stock Units | D | -4.125 | 0 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Schuling Douglas A | SGNL | Common Stock | D | 5.000 | 10.500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Schuling Douglas A | SGNL | Common Stock | D | 4.125 | 5.500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Smith Robin L | SGNL | Stock Option (Right to Buy) | D | 1,62 | 18.000 | 18.000 | |||||
| 2015-08-10 | 2015-08-06 | 4 | Smith Robin L | SGNL | Restricted Stock Units | D | -4.125 | 0 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Smith Robin L | SGNL | Common Stock | D | 5.000 | 10.500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | Smith Robin L | SGNL | Common Stock | D | 4.125 | 5.500 | ||||||
| 2015-08-10 | 2015-08-06 | 4 | LEBOW BENNETT S | SGNL | Stock Option (Right to Buy) | D | 1,62 | 18.000 | 18.000 | |||||
| 2015-08-10 | 2015-08-06 | 4 | LEBOW BENNETT S | SGNL | Common Stock | D | 5.000 | 5.000 | ||||||
| 2015-08-05 | 2015-08-04 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | -23.000 | 69.000 | ||||||
| 2015-08-05 | 2015-08-04 | 4 | SEYMOUR TAMARA A | SGNL | Common Stock | D | 1,5600 | -8.522 | -13 | 14.478 | ||||
| 2015-08-05 | 2015-08-04 | 4 | SEYMOUR TAMARA A | SGNL | Common Stock | D | 23.000 | 23.000 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Smith Robin L | SGNL | Restricted Stock Units | D | -1.375 | 4.125 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Smith Robin L | SGNL | Common Stock | D | 1.375 | 1.375 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Schuling Douglas A | SGNL | Restricted Stock Units | D | -1.375 | 4.125 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Schuling Douglas A | SGNL | Common Stock | D | 1.375 | 1.375 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Gonyer David A | SGNL | Restricted Stock Units | D | -1.375 | 4.125 | ||||||
| 2015-07-21 | 2015-07-17 | 4 | Gonyer David A | SGNL | Common Stock | D | 1.375 | 1.375 | ||||||
| 2015-06-23 | 2015-06-19 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | -124.252 | 248.503 | ||||||
| 2015-06-23 | 2015-06-19 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 1,5100 | -46.036 | -70 | 331.130 | ||||
| 2015-06-23 | 2015-06-19 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 124.252 | 377.166 | ||||||
| 2015-04-10 | 2015-04-08 | 4 | Riccitelli Samuel D | SGNL | Restricted Stock Units | D | -372.756 | 372.755 | ||||||
| 2015-04-10 | 2015-04-08 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 2,0800 | -119.842 | -249 | 252.914 | ||||
| 2015-04-10 | 2015-04-08 | 4 | Riccitelli Samuel D | SGNL | Common Stock | D | 372.756 | 372.756 | ||||||
| 2014-08-04 | 2014-08-04 | 4 | SEYMOUR TAMARA A | SGNL | Restricted Stock Units | D | 92.000 | 92.000 | ||||||
| 2014-07-21 | 2014-07-17 | 4 | Smith Robin L | SGNL | Restricted Stock Units | D | 5.500 | 5.500 | ||||||
| 2014-07-21 | 2014-07-17 | 4 | Smith Robin L | SGNL | Stock Option (right to buy) | D | 5,60 | 6.000 | 6.000 | |||||
| 2014-07-21 | 2014-07-17 | 4 | Gonyer David A | SGNL | Restricted Stock Units | D | 5.500 | 5.500 | ||||||
| 2014-07-21 | 2014-07-17 | 4 | Gonyer David A | SGNL | Stock Option (right to buy) | D | 5,60 | 6.000 | 6.000 | |||||
| 2014-07-21 | 2014-07-17 | 4 | Schuling Douglas A | SGNL | Restricted Stock Units | D | 5.500 | 5.500 | ||||||
| 2014-07-21 | 2014-07-17 | 4 | Schuling Douglas A | SGNL | Stock Option (right to buy) | D | 5,60 | 6.000 | 6.000 | |||||
| 2014-06-17 | 3 | LEBOW ALPHA, LLLP By LeBow Alpha, LLLP | SGNL | Common Stock, par value $0.01 per share | I | 4.465.258 | ||||||||
| 2014-06-17 | 3 | LEBOW ALPHA, LLLP By LeBow Alpha, LLLP | SGNL | Common Stock, par value $0.01 per share | I | 4.465.258 | ||||||||
| 2014-06-17 | 3 | LEBOW ALPHA, LLLP By LeBow Alpha, LLLP | SGNL | Common Stock, par value $0.01 per share | I | 4.465.258 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
